ALTER — Theradiag SA Share News
0.000.00%
Last trade - 00:00- €16.44m
- €12.36m
- €12.20m
Brief: Biosynex Proposes Merger With Theradiag
Brief: Theradiag H1 Revenue Up At EUR 6.7 MLN
Brief: Theradiag Reports Revenue Growth Of 9.7% In 2022
Brief: Theradiag FY Operating Loss Narrows To EUR 0.3 Million
Brief: Theradiag Appoints Christian Policard As Chairman and CEO
Brief: Reopening Of Biosynex Offer On Theradiag Shares
Brief: Biosynex: Successful Takeover Bid Initiated For Theradiag Shares
Brief: Theradiag FY Revenue Up At EUR 12.2 Mln
Brief: Biosynex Provides Details On Public Tender Offer On Theradiag Shares
Brief: Biosynex Announces Voluntary Public Tender Offer On Theradiag's Shares
Brief: Theradiag H1 Operating Loss Narrows To EUR 0.1 Million
Brief: Theradiag H1 Revenue Up At 6.3 Million Euros
Brief: Theradiag, Quotient Ltd Partner On Autoimmune Disease Diagnostics
Brief: Theradiag Announces Launch Of ez-Track1
Brief: Theradiag FY Operating Loss Widens To EUR 0.9 Million
Brief: Theradiag FY Revenue Up 7% At 11.1 Million Euros
Theradiag shares rise on COVID test distribution deal with Biosynex
Brief: Theradiag, Biosynex Sign Distribution Agreement On AMPLIQUICK SARS-CoV-2 PCR Test
Brief: Theradiag Announces Launch Of 4 New i-Tracker Kits